Summary
In evaluating factor-VIII activity it should be noted that regarding the remaining activity of deficient plasma a linear reference curve is achieved. In the standard population factor-VIII activity and factor-VIII associated protein are distributed approximately lognormally. Due to this distribution certain results have been gained for the optimal choice of localisation and dispersion measures. It is assumed that the proportions of neutralized factor-VIII activity in plasma are distributed according to Poisson. The applicability of the Poisson distribution was also proved for the free factor-VIII activity portion. Due to the Poisson distribution the antibody unit is clearly defined, thus eliminating a further discussion on the establishment of an arbitrary standardized antibody unit.
Zusammenfassung
Bei der Bestimmung der Faktor VIII-Aktivität sollte beachtet werden, daß durch Berücksichtigung der Restaktivität des Mangelplasmas eine Linearisierung der Bezugskurve erreicht wird. Faktor VIII-Aktivität und Faktor VIII-assoziiertes Protein sind in der Normalpopulation annähernd lognormal verteilt. Aus dieser Verteilung ergeben sich für die Wahl der besten Lokalisations- und Dispersionsmaße Konsequenzen. Es wird angenommen, daß die Anteile der neutralisierten Faktor VIII-Aktivität im Plasma poissonverteilt sind. Für den Anteil der freien Faktor VIII-Aktivität konnte die Anwendbarkeit der Poisson-Verteilung nachgewiesen werden. Durch die Poisson-Verteilung ist die Antikörpereinheit eindeutig definiert. Hierdurch würde sich die weitere Diskussion über die Festsetzung einer arbiträren einheitlichen Antikörpereinheit erübrigen.
Similar content being viewed by others
Literatur
Bangham, D. R., Brozovič, M.: Factor VIII international units and reference materials. Thrombos. Diathes. haemorrh. (Stuttg.)31, 3 (1974)
Biggs, R.: Human blood coagulation, haemostasis and thrombosis, S. 614. Oxford: Blackwell 1972
Biggs, R.: The absorption of human factor VIII neutralizing antibody by factor VIII. Brit. J. Haemat.26, 259 (1974)
Biggs, R., Bidwell, E.: A method for the study of antihaemophilic globulin inhibitors with reference to six cases. Brit. J. Haemat.5, 379 (1959)
Biggs, R., Austen, D. E. G., Denson, K. W. E., Rizza, C. R., Borrett, R.: The mode of action of antibodies which destroy factor VIII. I. Antibodies which have second-order concentration graphs. Brit. J. Haemat.23, 125 (1972)
Biggs, R., Austen, D. E. G., Denson, K. W. E., Borrett, R., Rizza, C. R.: The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs. Brit. J. Haemat.23, 137 (1972)
Cann, J. R.: A phenomenological theory of rocket immunoelectrophoresis. Biophys. Chem.3, 206 (1975)
Denson, K. W. E.: Standardisation of methods for the determination of antihaemophilic factors. In: Proceedings of the VIth Congress of the World Federation of Haemophilia, S. 82, Baden, Vienna, 1970
Denson, K. W. E., Biggs, R.: Laboratory diagnosis, tests of clotting function and their standardisation. In: Human blood coagulation, haemostasis and thrombosis. Bigg, R. (ed.), S. 295. Oxford: Blackwell 1972
Egeberg, O.: Assay of antihemophilic A, B and C factors by one-stage cephalin systems. Scand. J. Clin. Lab. Invest.13, 140 (1961)
Girolami, A., Sticchi, A., Barbui, T., Bareggi, G.: Factor VIII immunological assay. An evaluation of several methods using whole plasma. Blut29, 309 (1974)
Hardisty, R. M., Macpherson, J. C.: A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. With a note on the calculation of confidence limits by G.I.C. Ingram. Thrombos. Diathes. haemorrh. (Stuttg.)7, 215 (1962)
Holmberg, L., Nilsson, I. M.: Immunologic studies in haemophilia A. Scand. J. Haemat.10, 12 (1973)
Hoyer, L. W.: Immunologic studies of antihemophilic factor (AHF, factor VIII). III. Comparative binding properties of human and rabbit anti-AHF. Blood39, 481 (1972)
Jeremic, M., Weisert, O., Gedde-Dahl, T.W.: Factor VIII (AHG) levels in 1016 regular blood donors. The effects of age, sex, and ABO blood groups. Scand. J. clin. Lab. Invest.36, 461 (1976)
Kasper, C. K. et al.: A more uniform measurement of factor VIII inhibitors. Thrombos. Diathes. haemorrh. (Stuttg.)34, 869 (1975)
Kasper, C. K., Pool, J. G.: Measurement of mild factor VIII inhibitors in Bethesda units. Thrombos. Diathes. haemorrh. (Stuttg.)34, 875 (1975)
Koutts, J., Meyer, D., Rickard, K., Stott, L., Firkin, B. G.: Heterogeneity in biological activity of human factor VIII antibodies. Brit. J. Haemat.29, 99 (1975)
Langdell, R. D., Wagner, R. H., Brinkhous, K. M.: Effect of antihemophilic factor on onestage clotting tests. J. Lab. Clin. Med.41, 637 (1953)
Laurell, C. B.: Electroimmuno assay. Scand. J. clin. Lab. Invest.29, Suppl. 124, 21 (1972)
Lechner, K.: Inactive factor VIII in hemophilia A and Willebrand's disease. A study of 117 cases. Acta Haemat.48, 257 (1972)
Moser, S., Pflugshaupt, R.: Vergleichende Untersuchungen über die Bestimmung der Faktor VIII-Aktivität. Schweiz. med. Wschr.104, 1372 (1974)
Penick, G. D., Roberts, H. R., McMillan, C. W.: Assays for antihemophilic factor (factor VIII). In: Thrombosis and bleeding disorders. Bang, N. U., Beller, F. K., Deutsch, E., Mammen, E. F. (eds.), S. 189. Stuttgart: Thieme; New York, London: Academic Press 1971
Pool, J. G., Miller, R. G.: Assay of the immun inhibitor in classic haemophilia: application of virus-antibody reaction kinetics. Brit. J. Haemat.22, 517 (1972)
Preston, A. E.: The factor VIII-activity in fresh and stored plasma. Brit. J. Haemat.13, 42 (1976)
Preston, A. E., Barr, A.: The plasma concentration of factor VIII in the normal population. II. The effects of age, sex and blood group. Brit. J. Haemat.10, 238 (1964)
Rizza, C. R., Biggs, R.: The treatment of patients who have factor VIII antibodies. Brit. J. Haemat.24, 65 (1973)
Sachs, L.: Statistische Auswertungsmethoden. Berlin, Heidelberg, New York: Springer 1972
Sell, E. A., Corrigan, J. J., Jr.: Platelet counts, fibrinogen concentrations, and factor V and factor VIII levels in healthy infants according to gestational age. Ariz. J. Pediat.82, 1028 (1973)
Shapiro, S. S.: The immunological character of acquired inhibitors of antihemophilic globulin (factor VIII) and the kinetics of their interaction with factor VIII. J. Clin. Invest.46, 147 (1967)
Veltkamp, J. J., Muller, A. D., Loeliger, E. A.: Indication, assay procedures, diagnosis, and advice. In: Human blood coagulation. Hemker, H.C., Loeliger, E.A., Veltkamp, J.J. (eds.), S. 173. Leiden: Leiden University Press 1969
Zimmermann, T. S., Ratnoff, O. D., Powell, A. E.: Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's disease. J. Clin. Invest.50, 244 (1971)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hintz, G. Aktuelle Gesichtspunkte zur Auswertung der Bestimmung von Faktor VIII-Aktivität, Faktor VIII-assoziiertem Protein und Faktor VIII-neutralisierendem Antikörper. Blut 36, 95–107 (1978). https://doi.org/10.1007/BF00996836
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00996836
Key words
- Factor-VIII activity
- Factor-VIII associated protein
- Factor-VIII neutralizing antibody
- Poisson distribution